163
Views
2
CrossRef citations to date
0
Altmetric
Research Article

The relationship of single-strand breaks in DNA to breast cancer risk and to tissue concentrations of oestrogens

, , , , , , , , & show all
Pages 689-697 | Received 22 Nov 2016, Accepted 06 Feb 2017, Published online: 28 Feb 2017

References

  • Anstead, G.M., Carlson, K.E., and Katzenellenbogen, J.A., 1997. The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site. Steroids, 62, 268–303.
  • Arslan, A.A., et al., 2009. Circulating estrogen metabolites and risk for breast cancer in premenopausal women. Cancer epidemiology, biomarkers & prevention, 18, 2273–2279.
  • Bandera, E.V., et al., 2015. Obesity, body fat distribution, and risk of breast cancer subtypes in African American women participating in the AMBER Consortium. Breast cancer research and treatment, 150, 655–666.
  • Bean, G.R., et al., 2007. Morphologically normal-appearing mammary epithelial cells obtained from high-risk women exhibit methylation silencing of INK4a/ARF. Clinical cancer research, 13, 6834–6841.
  • Biswas, M. and Chan, J.Y. 2010. Role of Nrf1 in antioxidant response element-mediated gene expression and beyond. Toxicology and applied pharmacology, 244, 16–20.
  • Borras, C., et al., 2003. Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. Free radical biology and medicine, 34, 546–552.
  • Boyd, N.F., et al., 2007. Mammographic density and the risk and detection of breast cancer. The New England journal of medicine, 356, 227–236.
  • Buisson, R., et al., 2015. Distinct but concerted roles of ATR, DNA-PK, and Chk1 in countering replication stress during S phase. Molecular cell, 59, 1011–1024.
  • Byng, J.W., et al., 1998. Analysis of mammographic density and breast cancer risk from digitized mammograms. Radiographics, 18, 1587–1598.
  • Caldecott, K.W. 2008. Single-strand break repair and genetic disease. Nature reviews genetics, 9, 619–631.
  • Cavalieri, E., et al., 2012. Mechanism of DNA depurination by carcinogens in relation to cancer initiation. IUBMB life, 64, 169–179.
  • Chatterton, R.T., et al., 2015. Methodological considerations in estrogen assays of breast fluid and breast tissue. Steroids, 99, 103–107.
  • Chen, S., et al., 2002. DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population. Carcinogenesis, 23, 1321–1325.
  • Divine, K.K., et al., 2001. The XRCC1 399 glutamine allele is a risk factor for adenocarcinoma of the lung. Mutation research, 461, 273–278.
  • Fabian, C.J., et al., 2000. Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model. Journal of the National cancer Institute, 92, 1217–1227.
  • Fabian, C.J., et al., 2002. A phase II breast cancer chemoprevention trial of oral alpha-difluoromethylornithine: breast tissue, imaging, and serum and urine biomarkers. Clinical cancer research, 8, 3105–3117.
  • Fabian, C.J., et al., 2010. Reduction in Ki-67 in benign breast tissue of high-risk women with the lignan secoisolariciresinol diglycoside. Cancer prevention research, 3, 1342–1350.
  • Fackler, M.J., et al., 2004. Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer. Cancer research, 64, 4442–4452.
  • Fernandez, S.V., Russo, I.H., and Russo, J. 2006. Estradiol and its metabolites 4-hydroxyestradiol and 2-hydroxyestradiol induce mutations in human breast epithelial cells. International journal of cancer, 118, 1862–1868.
  • Harvie, M., Hooper, L., and Howell, A.H., 2003. Central obesity and breast cancer risk: a systematic review. Obesity reviews, 4, 157–173.
  • Ishii, T., et al., 2008. Covalent modification of proteins by green tea polyphenol (-)-epigallocatechin-3-gallate through autoxidation. Free radical biology & medicine, 45, 1384–1394.
  • John, E.M., et al., 2014. Overall and abdominal adiposity and premenopausal breast cancer risk among hispanic women: the Breast Cancer Health Disparities Study. Cancer epidemiology, biomarkers & prevention, 24, 138–147.
  • Khan, S.A., et al., 2012. Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial. Cancer prevention research, 5, 309–319.
  • Krokan, H.E. and Bjoras, M., 2013. Base excision repair. Cold spring harbor perspectives in biology, 5, a012583.
  • Li, Z., et al., 2014. Cyclin D1 integrates estrogen-mediated DNA damage repair signaling. Cancer research, 74, 3959–3970.
  • Liehr, J.G., 1997. Dual role of oestrogens as hormones and pro-carcinogens: tumour initiation by metabolic activation of oestrogens. European journal of cancer prevention, 6, 3–10.
  • Masood, S., et al., 1990. Prospective evaluation of radiologically directed fine-needle aspiration biopsy of nonpalpable breast lesions. Cancer, 66, 1480–1487.
  • Mattingly, K.A., et al., 2008. Estradiol stimulates transcription of nuclear respiratory factor-1 and increases mitochondrial biogenesis. Molecular endocrinology, 22, 609–622.
  • Mitra, S., et al., 2007. Intracellular trafficking and regulation of mammalian AP-endonuclease 1 (APE1), an essential DNA repair protein. DNA repair (Amst), 6, 461–469.
  • Mitrunen, K. and Hirvonen, A., 2003. Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism. Mutation research, 544, 9–41.
  • Morimoto, L.M., et al., 2002. Obesity, body size, and risk of postmenopausal breast cancer: the Women’s Health Initiative (United States). Cancer causes control, 13, 741–751.
  • Ohtsuji, M., et al., 2008. Nrf1 and Nrf2 play distinct roles in activation of antioxidant response element-dependent genes. The journal of biological chemistry, 283, 33554–33562.
  • Pianetti, S., et al., 2002. Green tea polyphenol epigallocatechin-3 gallate inhibits Her-2/neu signaling, proliferation, and transformed phenotype of breast cancer cells. Cancer research, 62, 652–655.
  • Ryk, C., et al., 2006. Polymorphisms in the DNA repair genes XRCC1, APEX1, XRCC3 and NBS1, and the risk for lung cancer in never- and ever-smokers. Lung cancer, 54, 285–292.
  • Santen, R., et al., 2009. Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects. Annals of the New York academy of sciences, 1155, 132–140.
  • Savage, K.I., et al., 2014. Identification of a BRCA1-mRNA splicing complex required for efficient DNA repair and maintenance of genomic stability. Molecular cell, 54, 445–459.
  • Schweigert, N., Zehnder, A.J., and Eggen, R.I., 2001. Chemical properties of catechols and their molecular modes of toxic action in cells, from microorganisms to mammals. Environmental microbiology, 3, 81–91.
  • Shiloh, Y. 2003. ATM and related protein kinases: safeguarding genome integrity. Nature reviews cancer, 3, 155–168.
  • Stearns, V., et al., 2016. Gene methylation and cytological atypia in random fine needle aspirates for assessment of breast cancer risk. Cancer prevention research, 9, 673–682.
  • Sturgis, E.M., et al., 1999. Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis, 20, 2125–2129.
  • Suijkerbuijk, K.P., et al., 2008. Methylation is less abundant in BRCA1-associated compared with sporadic breast cancer. Annals of oncology, 19, 1870–1874.
  • Tambini, C.E., et al., 2010. The importance of XRCC2 in RAD51-related DNA damage repair. DNA repair, 9, 517–525.
  • Thangapazham, R.L., et al., 2007. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Cancer letters, 245, 232–241.
  • Wen, W., et al., 2005. Cytochrome P450 1B1 and catechol-O-methyltransferase genetic polymorphisms and breast cancer risk in Chinese women: results from the shanghai breast cancer study and a meta-analysis. Cancer epidemiology, biomarkers & prevention, 14, 329–335.
  • Whitehouse, C.J., et al., 2001. XRCC1 stimulates human polynucleotide kinase activity at damaged DNA termini and accelerates DNA single-strand break repair. Cell, 104, 107–117.
  • Yeh, C.W., et al., 2003. Suppression of fatty acid synthase in MCF-7 breast cancer cells by tea and tea polyphenols: a possible mechanism for their hypolipidemic effects. The pharmacogenomics journal, 3, 267–276.
  • Ying, S., et al., 2016. DNA-PKcs and PARP1 bind to unresected stalled DNA replication forks where they recruit XRCC1 to mediate repair. Cancer research, 76, 1078–1088.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.